1 |
R. Zheng & Y. Mao. (2017). Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study. Lipids in Health and Disease, 16(1), 175. DOI: 10.1186/s12944-017-0562-y
DOI
|
2 |
M. Laakso & Johanna Kuusisto. (2014). Insulin resistance and hyperglycaemia in cardiovascular disease development. Nature Reviews Endocrinology, 10(5), 293-302. DOI: 10.1038/nrendo.2014.29
DOI
|
3 |
L. You, A. Liu, G. Wuyun, H. Wu & P. Wang. (2014). Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area. Journal of Atherosclerosis and Thrombosis, 21(4), 355-365. DOI: 10.5551/jat.20529
DOI
|
4 |
D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher & R. C. Turner. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412-419. DOI: 10.1007/BF00280883
DOI
|
5 |
L. E. Simental-Mendia, M. Rodriguez-Moran & F. Guerrero-Romero. (2008). The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metabolic Syndrome and Related Disorders, 6(4), 299-304. DOI: 10.1089/met.2008.0034
DOI
|
6 |
T. Bardin & P. Richette. (2017). Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Medicine, 15(1), 123. DOI: 10.1186/s12916-017-0890-9
DOI
|
7 |
C. Borghi et al. (2015). Serum uric acid and the risk of cardiovascular and renal disease. Journal of Hypertension, 33(9), 1729-1741 DOI: 10.1097/HJH.0000000000000701
DOI
|
8 |
Y. Xu et al. (2013). Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis. Public Library of Science One, 8(10), e78206. DOI: 10.1371/journal.pone.0078206
DOI
|
9 |
Y. Zhu et al. (2014). High uric acid directly inhibits insulin signalling and induces insulin resistance. Biochemical and Biophysical Research Communications, 447(4), 707-714. DOI: 10.1016/j.bbrc.2014.04.080
DOI
|
10 |
S. Li et al. (2019). The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis. Scientific Reports, 9(1), 7320. DOI: 10.1038/s41598-019-43776-5
DOI
|
11 |
U. M. Khosla et al. (2005). Hyperuricemia induces endothelial dysfunction. Kidney International, 67(5), 1739-1742. DOI: 10.1111/j.1523-1755.2005.00273.x
DOI
|
12 |
F. Cortese et al. (2019). Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects. Vascular Pharmacology, 120, 106565. DOI: 10.1016/j.vph.2019.106565
DOI
|
13 |
E. Krishnan, C. K. Kwoh, H. R. Schumacher & L. Kuller. (2007). Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension, 49(2), 298-303. DOI: 10.1161/01.HYP.0000254480.64564.b6
DOI
|
14 |
D. Grassi et al. (2013). Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Current Pharmaceutical Design, 19(13), 2432-2438. DOI: 10.2174/1381612811319130011
DOI
|
15 |
D. Roy, M. Perreault & A. Marette. (1998). Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. American Journal of Physiology, 274(4), E692-E699. DOI: 10.1152/ajpendo.1998.274.4.E692
DOI
|
16 |
E. Muscelli et al. (1996). Effect of insulin on renal sodium and uric acid handling in essential hypertension. American Journal of Hypertension, 9(8), 746-752. DOI: 10.1016/0895-7061(96)00098-2
DOI
|
17 |
D. Toyoki et al. (2017). Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2. American Journal of Physiology-Renal Physiology, 313(3), F826-F834. DOI: 10.1152/ajprenal.00012.2017
DOI
|
18 |
M. E. Emukowhate, D. Perera & A. Wierzbicki. (2014). Dyslipidaemia related to insulin resistance and cardiovascular disease in South Asian and West African populations. Current Pharmaceutical Design, 20(40), 6270-6275. DOI: 10.2174/1381612820666140620114948
DOI
|
19 |
S. W. Yang, K. H. Park & Y. J. Zhou. (2016). The Impact of Hypoglycemia on the Cardiovascular System: Physiology and Pathophysiology. Angiology. 67(9), 802-809. DOI: 10.1177/0003319715623400
DOI
|
20 |
P. Angoorani et al. (2018). Validity of triglycerideglucose index as an indicator for metabolic syndrome in children and adolescents: the CASPIAN-V study. Eating and Weight Disorders, 23(6), 877-883. DOI: 10.1007/s40519-018-0488-z
DOI
|
21 |
J. P. Bastard, M. E. Lavoie, V. Messier, D. Prud'homme & R. Rabasa-Lhoret. (2012). Evaluation of two new surrogate indices including parameters not using insulin to assess insulin sensitivity/resistance in non-diabetic postmenopausal women: a MONET group study. Diabetes & Metabolism, 38(3), 258-263. DOI: 10.1016/j.diabet.2012.01.004
DOI
|
22 |
World Health Organization. (1999). Report of a WHO consultation on obesity: Preventing and managing, the global epidemic. Geneva.
|
23 |
W. Shi, L. Xing, L. Jing, Y. Tian & S. Liu. (2019). Usefulness of triglyceride-glucose index for estimating hyperuricemia risk: Insights from a general population. Postgraduate Medical Journal, 131(5), 348-356. DOI: 10.1080/00325481.2019.1624581
DOI
|
24 |
Q. Gu, X. Hu, J. Meng, J. Ge, S. J. Wang & X. Z. Liu. (2020). Associations of triglyceride-glucose index and its derivatives with hyperuricemia risk: A Cohort study in Chinese general population. International Journal of Endocrinology, 2020, 3214716. DOI: 10.1155/2020/3214716
DOI
|
25 |
J. S. Byun, J. N. Kim, Y. S. Song, Y. K. Roh & M. K. Choi. (2019). The relationship between hyperuricemia and triglyceride glucose index: Based on 2016 Korean National Health and Nutrition Examination Survey. Korean Journal of Family Practice, 9(3), 266-271. DOI: 10.21215/kjfp.2019.9.3.266
DOI
|
26 |
S. Kodama et al. (2009). Association between serum uric acid and development of type 2 diabetes. Diabetes Care, 32(9), 1737-1742. DOI: 10.2337/dc09-0288
DOI
|
27 |
J. L. Jin et al. (2018). Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease. Journal of Thoracic Disease, 10(11), 6137-6146. DOI: 10.21037/jtd.2018.10.79
DOI
|
28 |
K. L. Donnelly, C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt & E. J. Parks. (2005). Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. Journal of Clinical Investigation, 115(5), 1343-1351. DOI: 10.1172/JCI23621
DOI
|
29 |
G. M. Reaven. (1988). Role of insulin resistance in human disease. Diabetes, 37(12), 1595-1607. DOI: 10.2337/diab.37.12.1595
DOI
|
30 |
E. Krishnan. (2014). Interaction of inflammation, hyperuricemia, and the prevalence of hypertension among adults free of metabolic syndrome: NHANES 2009-2010. Journal of the American Heart Association, 3(2), e000157. DOI: 10.1161/JAHA.113.000157
DOI
|
31 |
A. Sanchez-Garcia et al. (2020). Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review. International Journal of Endocrinology, 2020, 4678526. DOI: 10.1155/2020/4678526
DOI
|
32 |
N. Mikhail. (2009). The metabolic syndrome: insulin resistance. Current Hypertension Reports, 11(2), 156-158. DOI: 10.1007/s11906-009-0027-4
DOI
|
33 |
R. H. Eckel, S. M. Grundy & P. Z. Zimmet. (2005). The metabolic syndrome. Lancet, 365(9468), 1415-1428. DOI: 10.1016/S0140-6736(05)66378-7
DOI
|
34 |
G. Unger, S. F. Benozzi, F. Perruzza & G. L. Pennacchiotti. (2014). Triglycerides and glucose index: a useful indicator of insulin resistance. Endocrinology and Nutrition, 61(10), 533-540. DOI: 10.1016/j.endonu.2014.06.009
DOI
|
35 |
L. Sanchez-Inigo, D. Navarro-Gonzalez, A. Fernandez-Montero, J. Pastrana-Delgado & J. A. Martinez. (2016). The TyG index may predict the development of cardiovascular events. European Journal of Clinical Investigation, 46(2), 189-197. DOI: 10.1111/eci.12583
DOI
|
36 |
D. Navarro-Gonzalez, L. Sanchez-Inigo, J. Pastrana-Delgado, A. Fernandez-Montero & J. A. Martinez. (2016). Triglyceride-glucose index(TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The Vascular-Metabolic CUN cohort. Preventive Medicine, 86, 99-105. DOI: 10.1016/j.ypmed.2016.01.022
DOI
|